Annexon, Inc. (ANNX) vs Lexicon Pharmaceuticals, Inc. (LXRX)
- Annexon, Inc. ANNX 3.41 −5.28%
- Lexicon Pharmaceuticals, Inc. LXRX 1.52 −7.88%
Annexon, Inc. and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Annexon, Inc. and Lexicon Pharmaceuticals, Inc. are of similar size ($734.2M and $682.5M). Annexon, Inc. has the higher net margin (0.00% vs −147.4%) and the higher return on invested capital (0.00% vs −96.4%). Across the 14 metrics below, Lexicon Pharmaceuticals, Inc. leads on 8 and Annexon, Inc. on 6.
Valuation
Profitability
| Metric | ANNX | LXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 99.14% | 65.16% |
| Operating margin | 0.00% | (131.43%) | 0.00% |
| Net margin | 0.00% | (147.38%) | 0.00% |
| Free cash flow margin | 0.00% | (156.71%) | 0.00% |
| Return on equity | (105.26%) | (40.21%) | (56.36%) |
| Return on assets | (79.38%) | (25.70%) | (48.04%) |
| Return on invested capital | 0.00% | (96.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack